Study Reveals Daily Matcha Tea May Help Reverse Fatty Liver in Hong Kong Adults
AM730 · 1 SOURCESabout 1 hour ago5 MIN
Summary
A new study suggests that drinking matcha tea daily could help reverse fatty liver disease, offering hope for the estimated one in four Hong Kong adults affected by this condition. Researchers from Taipei Medical University conducted an animal experiment published in the international nutrition journal Nutrients, examining matcha's potential effects on fatty liver across multiple metabolic indicators.
Key Points
- CUHK data indicates approximately 25% of Hong Kong adults have fatty liver disease, linked to high-oil, high-sugar, and ultra-processed food diets
- The 12-week study used 48 rats divided into six groups, with some receiving matcha powder at 0.2% or 1% concentrations alongside either normal or junk food diets
- Matcha-supplemented groups showed significant reductions in liver total cholesterol and triglyceride accumulation, with improved insulin resistance indicators
- Researchers observed increased levels of beneficial gut bacteria including Akkermansia, Clostridium leptum, and Parabacteroides in matcha-fed rats
- The 1% matcha dose (equivalent to approximately 6 grams daily for a 60kg adult) demonstrated stronger protective effects against liver inflammation
- Matcha differs from regular green tea as it is made from shade-grown leaves ground into powder, allowing consumers to ingest the entire leaf and receive higher concentrations of catechins like EGCG
- Diabetes specialist Dr. Choi Ming-huu (蔡明劼) emphasized that while results are promising, animal findings cannot be directly applied to humans, and balanced diet with regular exercise remains fundamental for liver health
Why It Matters
With fatty liver disease affecting a quarter of Hong Kong's adult population, any accessible dietary intervention could have significant public health implications. The study provides scientific backing for matcha as a potential complementary approach alongside lifestyle modifications for managing metabolic-associated fatty liver disease .
With fatty liver disease affecting a quarter of Hong Kong's adult population, any accessible dietary intervention could have significant public health implications. The study provides scientific backing for matcha as a potential complementary approach alongside lifestyle modifications for managing metabolic-associated fatty liver disease .